My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Cancer Solid Tumors Bladder Cancer Tumor Neoplasms
For the latest version of this information please go to www.forpatients.roche.com